Gastrointestinal carcinoid tumors are relatively rare and tend to be slow-growing, but they can impact and compromise quality of life by obstructing food digestion and triggering a potentially serious condition called carcinoid syndrome. To ensure optimal treatment outcomes, early detection and prompt medical care is crucial.
City of Hope has one of the most experienced gastrointestinal carcinoid tumor programs in the United States, with a multidisciplinary team that takes an integrated approach to detecting and treating carcinoid tumors in the digestive tract. This includes using advanced technologies and specialized techniques such as:
minimally-invasive, robotically-assisted techniques
for complex surgeries that can remove tumors with less discomfort, reduced risk of complications and shorter recovery times
that can target hard-to-resect tumors with minimal exposure to surrounding normal tissue
targeted drugs and drug combinations that can treat advanced carcinoid tumors with greater effectiveness and fewer side effects, compared to traditional chemotherapy
combination regimens integrating surgery, radiation, chemotherapy and immunotherapy for maximum cancer-fighting effectiveness
Additionally, City of Hope patients have access to our extensive team of
supportive care experts
- including dieticians, supportive medicine physicians and rehabilitation specialists. Working closely with the patient’s primary care team, they can detect and address quality of life issues related to carcinoid tumors and their treatments. This includes
managing symptoms (such as pain, nausea and fatigue),
adjusting to a new diet and lifestyle post-treatment (particularly following more extensive treatments) and being aware of possible long-term effects.
As one of a handful of institutes to attain the elite designation of
Comprehensive Cancer Center by the National Cancer Institute,
City of Hope is acknowledged as a leader in gastrointestinal carcinoid tumor research and treatment. With our decades of experience, specialized therapy protocols and extensive program of
newly diagnosed or relapsed patients can find a treatment regimen that is tailored to their needs and gives them the best chance for survival. U.S. News & World Report
also named City of Hope as one of the top cancer hospitals in the country.
In collaboration with other departments and cancer centers, City of Hope’s gastrointestinal carcinoid cancer program has an active portfolio of clinical trials
studying novel treatments, including trials of new surgery, radiation and drug therapy regimens that are more effective against the disease and/or less harmful to the patient. Many of these promising therapies are only available to patients being treated at City of Hope.